Sound Pharmaceuticals, Inc.
Seattle, Washington, United States
Pharmaceutical company in Seattle, Washington
4010 Stone Way N # 120, Seattle, WA 98103
About Sound Pharmaceuticals, Inc.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Sound Pharmaceuticals, Inc.
During the past decade, Sound Pharmaceuticals, Inc. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
2005-11-01
2018-01-01
Completed
2,334
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Stress Management Therapy in Patients Receiving Chemotherapy for Cancer
2006-12-01
2010-05-01
Completed
442
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
2008-02-25
Active, not recruiting
165
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
2008-06-15
2015-05-28
Completed
210
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2012-06-18
Unknown status
1,070
AtriCure Exclusion of the LAA in Patients Undergoing Concomitant Cardiac Surgery
2008-09-01
2011-10-01
Completed
70
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Sound Pharmaceuticals, Inc.
According to Clinical.Site data, the most researched conditions in "Sound Pharmaceuticals, Inc." are
"Meniere's Disease" (1 trials) and "Noise Induced Hearing Loss" (1 trials). Many other conditions were trialed in "Sound Pharmaceuticals, Inc." in a lesser frequency.
Clinical Trials Intervention Types at Sound Pharmaceuticals, Inc.
Most popular intervention types in "Sound Pharmaceuticals, Inc." are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (1 trials), "SPI-1005" (1 trials), "SPI-1005 200mg" (1 trials) and "SPI-1005 400mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sound Pharmaceuticals, Inc.
The vast majority of trials in "Sound Pharmaceuticals, Inc." are
2 trials for "All" genders.
Clinical Trials Status at Sound Pharmaceuticals, Inc.
Currently, there are NaN active trials in "Sound Pharmaceuticals, Inc.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Sound Pharmaceuticals, Inc.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sound Pharmaceuticals, Inc., 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".